Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Mandy David, BS
Patient Support Professional Deputy Project Director
American Institutes for Research
1000 Thomas Jefferson Street, NW
Washington, DC, United States
Mandy David is a senior health communications specialist and a deputy project director at AIR. She is a certified physician assistant (PA), with specific training in sickle cell disease management. Additionally, she has been trained in addiction medicine, primary care and cardiac and basic life support. David has worked with pediatric, adult and geriatric patients, and has seven years’ experience working with sickle cell patients.
Before joining AIR, David served as a program and clinical manager at the Johns Hopkins University Sickle Cell Infusion Center, as well as a primary care PA at ULNACS Primary Care, and a neurosurgical and critical care PA at Georgetown University Hospital, among other PA positions. She is currently working toward her master of public health degree at the Johns Hopkins Bloomberg School of Public Health.
Representative Publications:
Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis
Related Content
-
Use of telemedicine to improve access to clinical services and treatment for children with sickle cell diseasePatients with sickle cell disease (SCD) ...
-
Charles Jonassaint, PhDDr. Jonassaint is a practicing clinical ...
-
Daniel E. Bauer, MD, PhDDaniel E. Bauer is currently engaged as ...
-
Dyspareunia is Associated With Chronic Pain in Premenopausal Women With Sickle Cell DiseaseObjectives: Pain is common in women wit...
-
Gene-Edited ‘Supercells’ Make Progress In Fight Against Sickle Cell DiseaseDoctors are reporting the first evidence...
-
My medical school lesson was tinged with racism. Did that affect how I treated a sickle cell patient years later?The young woman was curled up in a ball....
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...